Condition: s100b · Sponsor: Centre Hospitalier Universitaire de la Guadeloupe
Numerous studies have demonstrated the significant contribution of S100B blood level measurement in the management of minor to moderate traumatic brain injuries, notably by reducing the number of cranial computed tomography (CT) scans by at least one-third. However, physiological blood concentrations of the S100B protein may be higher in individuals with a Black phenotype compared to those with Asian or, in particular, Caucasian phenotypes. Assessing S100B protein levels in healthy individuals will help confirm the variability of its physiological concentration according to skin phenotype.
This description comes directly from the study's public registry record.
Valérie Hamony Soter · +590590934677 · valerie.soter@chu-guadeloupe.fr
Mélanie Petapermal · +590590934667 · melanie.petapermal@chu-guadeloupe.fr
Always discuss trial participation with your own doctor first.
| CH de la Basse-Terre | Basse-Terre, Guadeloupe | Recruiting |
| Chu de La Guadeloupe | Pointe-à-Pitre, Guadeloupe | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06998381